首页> 外文期刊>Journal of diabetes and its complications >Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring
【24h】

Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring

机译:替尼格列汀改善2型糖尿病血液透析患者的血糖控制:通过连续血糖监测评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aims: Recent reports suggest that appropriate glycemic control without hypoglycemia could decrease mortality in patients with diabetes mellitus (DM) and end-stage renal disease (ESRD). However, an indication of oral anti-diabetic drugs is limited in this population. The aim of this study was to evaluate efficacy of teneligliptin, a novel DPP-4 inhibitor, by continuous glucose monitoring (CGM) in patients with type 2 DM (T2DM) on hemodialysis (HD).
机译:目的:最近的报告表明,在没有低血糖的情况下进行适当的血糖控制可以降低患有糖尿病(DM)和晚期肾病(ESRD)的患者的死亡率。但是,该人群中口服抗糖尿病药的适应症有限。这项研究的目的是通过对血液透析(HD)的2型DM(T2DM)患者进行连续葡萄糖监测(CGM)来评估新型DPP-4抑制剂Teneligliptin的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号